Galderma Group AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 11, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	38,745	23,909	-	-	-
Enterprise Value	40,645	26,211	-	-	-
Last Close Price	163.20	100.47	-	-	-
PE Ratio	129.10	114.22	-	-	-
Forward PE	49.15	43.27	-	-	-
PS Ratio	10.39	5.94	-	-	-
PB Ratio	6.30	3.39	-	-	-
P/FCF Ratio	57.72	73.29	-	-	-
P/OCF Ratio	51.23	54.07	-	-	-
PEG Ratio	1.49	1.02	-	-	-
EV/Sales Ratio	10.90	6.52	-	-	-
EV/EBITDA Ratio	50.25	32.46	-	-	-
EV/EBIT Ratio	68.42	43.11	-	-	-
EV/FCF Ratio	60.55	80.35	-	-	-
Debt / Equity Ratio	0.37	0.35	0.91	1.27	1.25
Debt / EBITDA Ratio	2.80	3.00	5.83	8.68	9.67
Debt / FCF Ratio	3.37	7.66	111.57	583.27	39.02
Asset Turnover	0.37	0.35	0.33	0.31	-
Inventory Turnover	3.15	3.29	2.86	3.03	-
Quick Ratio	0.76	0.89	0.72	0.52	0.55
Current Ratio	1.09	1.21	1.03	0.77	0.82
Return on Equity (ROE)	4.92%	3.51%	-1.16%	-2.15%	-
Return on Assets (ROA)	3.67%	3.34%	3.04%	2.01%	-
Return on Capital (ROIC)	4.41%	4.03%	3.71%	2.46%	-
Return on Capital Employed (ROCE)	6.70%	6.10%	5.60%	3.80%	3.30%
Earnings Yield	0.78%	0.88%	-	-	-
FCF Yield	1.73%	1.36%	-	-	-
Dividend Yield	0.09%	0.15%	-	-	-
Buyback Yield / Dilution	95.82%	95.82%	-9.65%	-	-
Total Shareholder Return	95.91%	95.97%	-9.65%	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.